Multiple Sclerosis, Depression, and Suicide
BMJ 315:691-692, Feinstein,A., 1997
ALS & Severe Cervical Spondylotic Myelopathy in Pt with a Posterior Fossa Archnoid Cyst:Diag Dilemma
South Medical J 80:1580-1583, Lee,S.K.&Kelly,D.L., 1997
"Idiopathic"Cranial Hypertrophic Pachymeningitis Responsive to Antiotuberculous Therapy:Case Report
Neurosurg 41:965-971, Parney,I.F.,et al, 1997
Quality of Life Among Persons with Multiple Sclerosis and Their Caregivers
Neurol 48:74-80, Aronson,K.J., 1997
Randomised Placebo-Controlled Trial of Monthly IVIg Therapy in Relapsing-Remitting MS
Lancet 349:589-593, 5861997., Fazekas,F.,et al, 1997
A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial of Influenza Immunizaation in MS
Neurol 48:312-314, Miller,A.E.,et al, 1997
High Signal Intensity on T1 Weighted MRI of Anterolateral Column of Spinal Cord of Amyotrophic lateral Sclerosis
JNNP 62:88-91, Waragai,M.,et al, 1997
Prognosis in Familial ALS:Progr & Surv in Pts with glu100gly & ala4val Mutations in Cu, Zn Superoxide Dismutase
Neurol 48:55-57, Juneja,T.,et al, 1997
HLA Typing in Acute Optic Neuritis, Relation to MS & Magnetic Resonance Imaging Findings
Arch Neurol 54:76-80, Frederiksen,J.L.,et al, 1997
CIDP:Clinical Features & Responses to Trtm in 67 Consecutive Pts with/without a Monoclonal Gammopathy
Neurol 48:321-328, Gorson,K.G.,et al, 1997
Volumetric MRI Analysis Comparing Subjects Having Attention-Deficit Hyperactivity Disorder with Normal Controls
Neurol 48:589-601, Filipek,P.A.,et al, 1997
Neuroanatomy in Rett Syndrome:Cerebral Cortex and Posterior Fossa
Neurol 48:399-407, Subramaniam,B.,et al, 1997
Longitudinal Change in Basal Ganglia Volume in Patients with Huntington's Disease
Neurol 48:394-399, Aylward,E.H.,et al, 1997
Medial Temporal Lobe Volumetrics in Traumatic Brain Injury
AJNR 18:25-28, Jack,C.R.,et al, 1997
Cavernous Angioma of the Brain Stem Mimicking Multiple Sclerosis
NEJM 336:875-876, Vrethem,M.,et al, 1997
Clinicopath Conf
Oligodendroglioma, Mixed with Low-Grade Astrocytoma, Multiple Sclerosis, Case 12-1997, NEJM 336:1163, 11717., 1997
Concurrence of Multiple Sclerosis and Brain Tumor:Clinical Considerations
Neurol 48:1330-1333, Khan,O.A.,et al, 1997
A 36-Year-Old Woman Recuperating From a Stroke
JAMA 277:1970-1976, Alexander,M., 1997
Offspring Recurrence Rates and Clinical Characteristics of Conjugal Multiple Sclerosis
Lancet 349:1587-1590, Robertson,N.P.,et al, 1997
Amelioration of Refractory Dysesthetic Limb Pain in Multiple Sclerosis by Gabapentin
Neurol 49:304-305, Samkoff,L.M.,et al, 1997
Doctors & Pts Don't Agree:Cross Sectional Study of Pts' & Doctors'Perceptions & Assessments of Disability in MS
BMJ 314:1580-1583, Rothwell,P.M.,et al, 1997
The Impact of Inpatient Rehabilitation on Progressive Multiple Sclerosis
Ann Neurol 42:236-244, Freeman,J.A.,et al, 1997
Interferon Beta Results in Immediate Reduction of Contrast-Enhanced MRI Lesions in MS Pts Followed by Weekly MRI
Neurol 48:1446-1448, Calabresi,P.A.,et al, 1997
Character of MRI Response to Trtm with Interferon Beta-1B:Enhancing MRI Lesion Freq as Prim Outcome Measure
Neurol 49:862-869, Stone,L.A.,et al, 1997
Impact of Interferon Beta-1A On Neurologic Disability in Relapsing Multiple Sclerosis
Neurol 49:358-363, Rudick,R.A.,et al, 1997
Quantitative Assessment of Sustained-Release 4-Aminopyridine for Symptomatic Treatment of Multiple Sclerosis
Neurol 48:817-821, Schwid,S.R.,et al, 1997
Glatiramer Acetate for Relapsing Multiple Sclerosis
The Medical Letter 39:61-62, , 1997
Serum Angiotensin-Converting Enzyme in Multiple Sclerosis
Arch Neurol 54:1012-1015, Constantinescu,C.S.,et al, 1997
Hemiageusia:An Unusual Presentation of Multiple Sclerosis
JNNP 54:657, Pascual-Leone,A.,et al, 1997
Serial Neuropsychological Assess & Magnetic Resonance Imagingf Analysis in Multiple Sclerosis
Arch Neurol 54:1018-1025, Hohol,M.J.,et al, 1997
Balos Concentric Sclerosis: A Clinical Case Study of Brain MRI, Biopsy, and Proton Magnetic Resonance Spectroscopic Findings
JNNP 62:655-658, Kim, M.O.,et al, 1997
Adult-Onset Subacute Sclerosing Panecephalitis:Case Reports and Review of the Literature
Mov Dis 12:342-353, Singer,C.,et al, 1997
Candidal Meningitis in HIV-Infected Patients: Analysis of 14 Cases
Clin Inf Dis 25:473-476, Casado, J.L.,et al, 1997
Refractory Epilepsy:Comparison of MR Imaging, CT, and Histopathologic Findings in 117 Patients
Radiology 201:97-105, Bronen,R.A.,et al, 1996
Massive Nerve Root Enlargement in Chronic Inflammatory Demyelinating Polyneuropathy
JNNP 61:636-640, Schady,W.,et al, 1996
Bilateral Ptosis Due to Mesencephalic Lesions with Relative Preservation of Ocular Motility
J Neuro-Ophthalmol 16:258-263, Martin,T.J.,et al, 1996
Three Get Ready
Arch Neurol 53:1222-1223, Goldblatt,D., 1996
Riluzole
Lancet 348:795-799, Wokke,J., 1996
Immunoassays Fail to Detect Antibodies Against Neuronal Calcium Channels in Amyotrophic Lateral Sclerosis Serum
Ann Neurol 40:695-700, 6911996., Arsac,C.,et al, 1996
Comparison of Triple Dose vs Std Dose Gadolinium-DTPA for Detect of MRI Enhanc Lesions in Pts with MS
Neurol 46:379-384, Filippi,M.,et al, 1996
Interferon Beta in Multiple Sclerosis
BMJ 313:1159, 1157, 1195996., Richards,R.G., 1996
Increased Writing Activity in Neurological Conditions:A Review and Clinical Study
JNNP 61:510-514, vanVugt,P.,et al, 1996
Neutralizing Antibodies During Treatment of Multiple Sclerosis with Interferon Beta-1b
IFNB MS Study Group & UBC MS. MRI Analysis Group, Neurol 47:889-8946., , 1996
Guidelines for Physicians with Patients on IFNB-1b:The Use of an Assay for Neutralizing Antibodies (NAB)
Neurol 47:865-866, Paty,D.,et al, 1996
Cytomegalovirus Encephalitis
Ann Int Med 125:577-578, Arribas,J.R.,et al, 1996
Hypothermia in Multiple Sclerosis
JNNP 61:369-375, White,K.D.,et al, 1996
Motor Neuron Disease with Parkinsonism
Arch Neurol 53:987-991, Qureshi,A.I.,et al, 1996
Age on Onset, Sex, & Cardiomyopathy as Predictors of Disability and Survival in Friedreich's Disease
Neurol 47:1260-1264, DeMichele,G.,et al, 1996
Low-Dose Oral Methotrexate in Chronic Progressive Multiple Sclerosis:Analyses of Serial MRIs
Neurol 47:1153-1157, Goodkin,D.E.,et al, 1996
Linomide Reduces the Rate of Active Lesions in Relapsing-Remitting Multiple Sclerosis
Neurol 47:895-900, Anderson,O.,et al, 1996